While both drugs are effective, tirzepatide's dual-agonist mechanism, targeting both GIP and GLP-1 receptors, is widely believed to be the reason for its weight loss results in clinical studies
The same logic applies if you're using Tirzepatide for weight management but have other co-morbidities that pose a risk to donation
Both are manufactured by licensed 503A compounding pharmacies meeting FDA pharmaceutical standards
piktogramok High active agent contentA product with an extra high amount of active agents
If you have obesity or a related condition, your doctor may request prior authorization to help get it covered
Weight loss drugs such as semaglutide and tirzepatide available under brand names including Ozempic, Wegovy and Mounjaro mimic the naturally-occurring hormone glucagon like peptide-1 (GLP-1), released into the blood in response to eating